Australia TGA ARTG recordMedicine chamber spacer
Australia TGA ARTG Registered Device · GlaxoSmithKline Australia Pty Ltd · GSK Consumer Healthcare (GMDT) · Class I · Started April 01, 2019
Good Name: GlaxoSmithKline Australia Pty Ltd - Medicine chamber spacer
- Risk Class
- Class I
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- April 01, 2019
- Effective Date
- April 01, 2019
- Country
- Ireland
- Address
- Clocherane Youghal Road, Dungarvan, Co Waterford
The Volumatic Spacer Device is a breath activated holding device designed to enable the use of the pressurised metered dose inhaler by a patient. A chamber for use with Seretide, Ventolin and Flixotide metered dose aerosol inhalers, designed to hold the spray before it is breathed in.
Access comprehensive regulatory information for Medicine chamber spacer in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by GlaxoSmithKline Australia Pty Ltd, manufactured by GSK Consumer Healthcare (GMDT) in Ireland. The device registration started on April 01, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.